机构：[1]Joint Laboratory of Artificial Intelligence for Critical Care Medicine, Department of Critical Care Medicine and Institutes for Systems Genetics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, P.R. China四川大学华西医院[2]iGlobal Research and Publishing Foundation, New Delhi, India[3]Chitkara College of Pharmacy, Chitkara University Punjab, Rajpura, India[4]Jan Nayak Ch. Devi Lal Memorial College of Pharmacy, Sirsa, Haryana, India[5]Amity Institute of Molecular Medicine & Stem Cell Research, Amity University, Sector-125, Noida, India[6]Department of Pharmaceutical Sciences and Drug Research, Punjabi University Patiala, Patiala, India[7]Amity Institute of Pharmacy, Amity University, Noida, India[8]Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, Haryana, India[9]Department of Pharmaceutics, Delhi Pharmaceutical Sciences and Research University, PushpVihar, Govt. of NCT of Delhi, New Delhi, India[10]Centre for Advanced Formulation and Technology (CAFT), Delhi Pharmaceutical Sciences and Research University, PushpVihar, Govt. of NCT of Delhi, New Delhi, India[11]ER Stress and Mucosal Immunology Lab, School of Health Sciences, University of Tasmania, Launceston, Tasmania, Australia[12]and School of Medicine, University of California San Francisco, San Francisco, CA, USA[13]School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India[14]Department of Rasa Shastra and Bhaishajya Kalpana, Faculty of Ayurveda, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India
Department of Scientific and Industrial
Research, Government of India (Ref No. – E-1719/JS&FA/DSIR;
DSIR/CRTDH/DPSRU(AH)2021).
语种：
外文
PubmedID：
第一作者：
第一作者机构：[1]Joint Laboratory of Artificial Intelligence for Critical Care Medicine, Department of Critical Care Medicine and Institutes for Systems Genetics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, P.R. China[2]iGlobal Research and Publishing Foundation, New Delhi, India
共同第一作者：
通讯作者：
通讯机构：[1]Joint Laboratory of Artificial Intelligence for Critical Care Medicine, Department of Critical Care Medicine and Institutes for Systems Genetics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, P.R. China[13]School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India[14]Department of Rasa Shastra and Bhaishajya Kalpana, Faculty of Ayurveda, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India
推荐引用方式(GB/T 7714)：
Dubey Ankit Kumar,Kaur Ishnoor,Madaan Reecha,et al.Unlocking the potential of oncology biomarkers: advancements in clinical theranostics[J].Drug Metabolism And Personalized Therapy.2024,doi:10.1515/dmpt-2023-0056.
APA：
Dubey Ankit Kumar,Kaur Ishnoor,Madaan Reecha,Raheja Shikha,Bala Rajni...&Sharma Rohit.(2024).Unlocking the potential of oncology biomarkers: advancements in clinical theranostics.Drug Metabolism And Personalized Therapy,,
MLA：
Dubey Ankit Kumar,et al."Unlocking the potential of oncology biomarkers: advancements in clinical theranostics".Drug Metabolism And Personalized Therapy .(2024)
